sintilimab,oxaliplatin,capecitabine
eli lilly,innovent biologics
['sintilimab', 'gastric', 'orient16', 'innovent']
#innovent releases final analysis results of #orient16: the phase 3 study of #sintilimab in combination with #chemotherapy for the first-line treatment of #gastriccancer at the #aacr23 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.